Drug Combination Details
General Information of the Combination (ID: C03726) | |||||
---|---|---|---|---|---|
Name | Pterostilbene NP Info | + | 5-fluorouracil Drug Info | ||
Structure |
![]() |
+ |
![]() |
||
Disease |
Colon cancer
[ICD-11: 2B90]
|
Investigative | [1] |
Combinatorial Therapeutic Effect(s) Validated Clinically or Experimentally | ||||||
---|---|---|---|---|---|---|
α. Enhancing Drug Efficacy by This Combination | ||||||
Achieving Therapeutic Synergy | Click to Show/Hide | |||||
Experiment 1 Reporting the Effect of This Combination | [1] | |||||
Molecule(s)
Regulation |
Up-regulation | Expression | BAX | Molecule Info |
Pathway MAP
|
|
Down-regulation | Expression | BCL-2 | Molecule Info |
Pathway MAP
|
||
Up-regulation | Expression | FOXO1 | Molecule Info |
Pathway MAP
|
||
Up-regulation | Expression | IFI27 | Molecule Info | |||
Up-regulation | Cleavage | PARP1 | Molecule Info |
Pathway MAP
|
||
In-vitro Model | Caco-2 | CVCL_0025 | Colon adenocarcinoma | Homo sapiens | ||
HCT 116 | CVCL_0291 | Colon carcinoma | Homo sapiens | |||
Experimental
Result(s) |
Pterostilbine sensitizes colon cancer cells to 5-fluorouracil cytotoxicity. |
References | ||||
---|---|---|---|---|
Reference 1 | Pterostilbine, an active component of blueberries, sensitizes colon cancer cells to 5-fluorouracil cytotoxicity. Sci Rep. 2015 Oct 16;5:15239. |




